Comparing two types of online weight loss programs

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of a group-based digital weight loss program delivered either asynchronously through an online platform or synchronously via weekly videoconference meetings. Participants will engage in a year-long program to determine if weight loss outcomes, engagement levels, and feelings of connection differ between the two delivery methods. The study will also assess the cost-effectiveness of each approach in terms of weight lost per dollar spent. By comparing these two methods, the trial seeks to identify which format may be more beneficial for participants in achieving their weight loss goals.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* BMI 27-45
* has Bluetooth or wifi connectivity at home (for scale)
* goes on Facebook at least 5 days per week over the past 2 weeks
* has posted/replied at least once a week in the past 2 weeks (per self-report)
* has a smart phone

Exclusion Criteria:

* Pregnant or lactating or plans to during study period
* bipolar disorder, substance abuse, psychosis, bulimia, binge eating disorder, or severe depression
* had bariatric surgery or plans to during the study
* currently taking meds affecting weight
* lost ≥5% of weight in past 6 months
* participating in another weight loss program or plans to during the study
* chronic pain or medical condition that interferes with the ability to exercise
* type 1 diabetes
* unable to walk ¼ mile unaided without stopping
* nicotine user

Where it's running

• University of Connecticut
  Storrs, Connecticut, United States Recruiting

Study contacts

• Principal investigator: Sherry Pagoto, PhD — University of Connecticut
• Study coordinator: Sherry Pagoto, PhD
• Email: sherry.pagoto@uconn.edu
• Phone: (860) 486-5917

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

• Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese

  This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).

  Recruiting Phase 3 Pfizer · Birmingham, Alabama and 3 other locations · NCT07915609

• Maridebart cafraglutide in people who switched from weekly GLP-1 receptor agonists

  This study tests how much maridebart cafraglutide appears in the blood after people with overweight or obesity switch from weekly GLP-1 receptor agonists.

  Recruiting at 9 sites Phase 1 Amgen · Phoenix, Arizona and 8 other locations · NCT07908316

• EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes

  This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.

  Recruiting Phase 3 Eli Lilly and Company · Tucson, Arizona and 74 other locations · NCT07881458

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.